Table 2.
Geometric mean antioxidant levels and interquartile range (IQR) for cardiovascular disease outcomes and all-cause mortality for 6961 men from Northern Ireland and France who were free of cardiovascular disease at entry
Antioxidant | CVD outcome | All-Cause Mortality | |||||
---|---|---|---|---|---|---|---|
μmol/L | All (n = 6961) | No (n = 6747) | Yes (n = 214) | p value | No (n = 6545) | Yes (n = 358) | p value |
Vitamin C | 33.8 (24.8–59.2) | 33.9 (25.0–59.2) | 29.8 (19.4–57.8) | 0.045 | 34.4 (25.5–59.4) | 24.1 (15.1–55.0) | < 0.001 |
Lycopene | 0.67 (0.42–1.34) | 0.67 (0.42–1.35) | 0.52 (0.31–1.09) | 0.001 | 0.68 (0.43–1.35) | 0.48 (0.27–1.08) | < 0.001 |
β-Carotene | 0.29 (0.17–0.51) | 0.29 (0.17–0.51) | 0.22 (0.11–0.39) | < 0.001 | 0.29 (0.18–0.52) | 0.20 (0.11–0.40) | < 0.001 |
α-Carotene | 0.11 (0.07–0.19) | 0.11 (0.07–0.19) | 0.08 (0.05–0.15) | < 0.001 | 0.11 (0.07–0.20) | 0.08 (0.05–0.15) | < 0.001 |
β-Cryptoxanthin | 0.70 (0.04–0.10) | 0.07 (0.04–0.10) | 0.06 (0.04–0.09) | 0.008 | 0.07 (0.04–0.11) | 0.05 (0.03–0.08) | < 0.001 |
Zeaxanthin | 0.04 (0.03–0.06) | 0.04 (0.03–0.06) | 0.04 (0.03–0.06) | 0.125 | 0.04 (0.03–0.06) | 0.04 (0.02–0.05) | < 0.001 |
Lutein | 0.21 (0.16–0.31) | 0.22 (0.16–0.31) | 0.19 (0.14–0.30) | 0.006 | 0.22 (0.16–0.31) | 0.17 (0.12–0.27) | < 0.001 |
α-Tocophorol | 26.0 (22.2–30.4) | 25.9 (22.1–30.4) | 26.8 (22.5–31.5) | 0.059 | 26.0 (22.3–30.5) | 24.6 (20.5–29.8) | < 0.001 |
γ-Tocophorol | 2.35 (1.88–2.95) | 2.35 (1.88–2.95) | 2.40 (1.93–2.96) | 0.375 | 2.35 (1.88–2.95) | 2.31 (1.84–2.86) | 0.422 |
Retinol | 2.24 (1.92–2.64) | 2.24 (1.92–2.64) | 2.22 (1.87–2.59) | 0.525 | 2.24 (1.93–2.64) | 2.15 (1.83–2.57) | 0.006 |